References
1. Dedov I.I., Mel’nichenko G.A. (eds). Endocrinology. National guidelines. Moscow: GEOTAR-Media, 2016: 1111 p. (in Russian)
2. Bruni R., Serino F.M., Galluzzo S., et al. Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels. Ann N Y Acad Sci. 2006; 1069: 208–11. DOI: https://doi.org/10.1196/annals.1351.018
3. Budnevsky A.V., Kutashov V.A., Priputnevich D.N., et al. Affective disorders on the background of hypothyroidism. Klinicheskaya meditsina [Clinical Medicine]. 2018; 96 (3): 222–7. DOI: https://doi.org/10.18821/0023-2149-2018-96-3-222-227 (in Russian)
4. Kutashov V.A., Budnevsky A.V., Ul’yanova O.V., Priputnevich D.N. The issue of neuropsychiatric disorders in patients with hypothyroidism. Saratovskiy nauchno-meditsinskiy zhurnal [Saratov Journal of Medical Scientific Research]. 2016; 12 (3): 375–8. (in Russian)
5. Provotorov V.M., Chernov Yu.N., Lyshova O.V., Budnevsky A.V. Alexithymia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Journal of Neurology and Psychiatry named after S.S. Korsakov]. 2000; 100 (6): 66–70. (in Russian)
6. Broytigam V., Kristian P., Rad M. Psychosomatic medicine. A short textbook. Moscow: GEOTAR-Meditsina, 1999: 373 p. (in Russian)
7. Westwood H., Kerr-Gaffney J., Stahl D., Tchanturia K. Alexithymia in eating disorders: systematic review and meta-analyses of studies using the Toronto alexithymia scale. J Psychosom Res. 2017; 99: 66–81. DOI: https://doi.org/10.1016/j.jpsychores.2017.06.007
8. Chaker L., Razvi S., Bensenor I.M., et al. Hypothyroidism. Nat Rev Dis Primers. 2022; 8 (1): 30. DOI: https://doi.org/10.1038/s41572-022-00357-7
9. Taylor P.N., Albrecht D., Scholz A., et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018; 14 (5): 301–16. DOI: https://doi.org/10.1038/nrendo.2018.18
10. Fadeev V.V., Morgunova T.B., Mel’nichenko G.A., Dedov I.I. Draft of the clinical recommendations for diagnosis and treatment of hypothyroidism. Klinicheskaya i eksperimental’naya tireodologiya [Clinical and Experimental Thyroidology]. 2021; 17 (1): 4–13. DOI: https://doi.org/10.14341/ket12702 (in Russian)
11. Jansen H.I., Boelen A., Heijboer A.C., et al. Hypothyroidism: the difficulty in attributing symptoms to their underlying cause. Front Endocrinol (Lausanne). 2023; 14: 1130661. DOI: https://doi.org/10.3389/fendo.2023.1130661
12. Jonklaas J., Bianco A.C., Bauer A.J., et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014; 24 (12): 1670–751. DOI: https://doi.org/10.1089/thy.2014.0028
13. Samuels M.H., Bernstein L.J. Brain fog in hypothyroidism: what is it, how is it measured, and what can be done about it. Thyroid. 2022; 32 (7): 752–63. DOI: https://doi.org/10.1089/thy.2022.0139
14. Morgunova T.B., Madiyarova M. Sh., Fadeev V.V. Treatment of primary hypothyroidism: unresolved issues. Klinicheskaya i eksperimental’naya tireodologiya [Clinical and Experimental Thyroidology]. 2015; 11 (1): 22–34. DOI: https://doi.org/10.14341/ket2015122-34 (in Russian)
15. Jonklaas J., Bianco A.C., Cappola A.R., et al. Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism: a consensus document. Eur Thyroid J. 2021; 10 (1): 10–38. DOI: https://doi.org/10.1159/000512970
16. Ettleson M.D., Bianco A.C. Individualized therapy for hypothyroidism: is T4 enough for everyone? J Clin Endocrinol Metab. 2020; 105 (9): e3090–104. DOI: https://doi.org/10.1210/clinem/dgaa430
17. Salas-Lucia F., Bianco A.C. T3 levels and thyroid hormone signaling. Front Endocrinol. 2022; 13: 1044691. DOI: https://doi.org/10.3389/fendo.2022.1044691
18. LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism. (T3-4-Hypo). URL: https://ichgcp.net/ru/clinical-trials-registry/NCT05682482
19. Mitchell A.L., Hegedüs L., Žarković M., et al. Patient satisfaction and quality of life in hypothyroidism: an online survey by the British thyroid foundation. Clin Endocrinol (Oxf). 2021; 94 (3): 513–20. DOI: https://doi.org/10.1111/cen.14340
20. van de Ven A.C., Netea-Maier R.T., de Vegt F., et al. Is there a relationship between fatigue perception and the serum levels of thyrotropin and free thyroxine in euthyroid subjects? Thyroid. 2012; 22 (12): 1236–43. DOI: https://doi.org/10.1089/thy.2011.0200
21. Siegmann E.M., Müller H.H.O., Luecke C., et al. Association of depression and anxiety disorders with autoimmune thyroiditis: a systematic review and meta-analysis. JAMA Psychiatry. 2018; 75 (6): 577–84. DOI: https://doi.org/10.1001/jamapsychiatry.2018.0190
22. Engum A., Bjoro T., Mykletun A., Dahl A.A. An association between depression, anxiety and thyroid function--a clinical fact or an artefact? Acta Psychiatr Scand. 2002; 106 (1): 27–34. DOI: https://doi.org/10.1034/j.1600-0447.2002.01250.x
23. Pankowski D., Wytrychiewicz-Pankowska K., Janowski K., et al. The role of illness-related beliefs in depressive, anxiety, and anger symptoms: an on-line survey in women with hypothyroidism. Front Psychiatry. 2021; 12: 614361. DOI: https://doi.org/10.3389/fpsyt.2021.614361
24. Samuels M.H., Kolobova I., Niederhausen M., et al. Effects of altering levothyroxine (L-T4) doses on quality of life, mood, and cognition in L-T4 treated subjects. J Clin Endocrinol Metab. 2018; 103 (5): 1997–2008. DOI: https://doi.org/10.1210/jc.2017-02668
25. Kotkowska Z., Strzelecki D. Depression and autoimmune hypothyroidism-their relationship and the effects of treating psychiatric and thyroid disorders on changes in clinical and biochemical parameters including BDNF and other cytokines – a systematic review. Pharmaceuticals (Basel). 2022; 15 (4): 391. DOI: https://doi.org/10.3390/ph15040391
26. Dmitrenko K. Yu., Khaykina I.A., Sadkova O.A., et al. Mental disorders in hypo- and hyperthyroidism: history of the problem and some hypotheses of potential psychosomatic research. Psikhiatriya [Psychiatry]. 2023; 21 (3): 64–78. DOI: https://doi.org/10.30629/2618-6667-2023-21-3-64-78 (in Russian)
27. Nuguru S.P., Rachakonda S., Sripathi S., et al. Hypothyroidism and depression: a narrative review. Cureus. 2022; 14 (8): e28201. DOI: https://doi.org/10.7759/cureus.28201
28. Quinque E.M., Karger S., Arélin K., et al. Structural and functional MRI study of the brain, cognition and mood in long-term adequately treated Hashimoto’s thyroiditis. Psychoneuroendocrinology. 2014; 42: 188–98. DOI: https://doi.org/10.1016/j.psyneuen.2014.01.015
29. Yin J., Xie L., Luo D., et al. Changes of structural and functional attention control networks in subclinical hypothyroidism. Front Behav Neurosci. 2021; 15: 725908. DOI: https://doi.org/10.3389/fnbeh.2021.725908
30. Cao J., Chen C., Zhang T., et al. Segmental abnormalities of white matter microstructure in primary hypothyroidism identified by automated fiber quantification. Neuroendocrinology. 2023; 113 (6): 589–605. DOI: https://doi.org/10.1159/000529062
31. Hogeveen J., Grafman J. Alexithymia. Handb Clin Neurol. 2021; 183: 47–62. DOI: https://doi.org/10.1016/b978-0-12-822290-4.00004-9
32. Holmes A., Marella P., Rodriguez C., et al. Alexithymia and cutaneous disease morbidity: a systematic review. Dermatology. 2022; 238 (6): 1120–9. DOI: https://doi.org/10.1159/000524736
33. Druk I.V. Alexithymia in patients with bronchial asthma on the background of connective tissue dysplasia. Omskiy psikhiatricheskiy zhurnal [Omsk Psychiatric Journal]. 2019; 3 (21): 17–20. (in Russian)